Session » Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis - Poster
-
Abstract Number: 321
Results of a Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Romosozumab in Men with Osteoporosis
-
Abstract Number: 322
The Activating Patients at Risk for Osteoporosis Study: A Randomized Trial within the Global Longitudinal Study of Osteoporosis in Women Cohort
-
Abstract Number: 323
Effect of 10 Years of Denosumab Treatment on Bone Histology and Histomorphometry in the Freedom Extension Study
-
Abstract Number: 324
A Placebo Controlled Trial of Vertebral Fill Technique Vertebroplasty for Acute Painful Osteoporotic Fracture (VAPOUR Trial)
-
Abstract Number: 325
Ebselen Is a Potential Anti-Osteoporosis Agent By Suppressing RANK Ligand-Induced Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In Vivo
-
Abstract Number: 326
Cortical Bone Changes in Pre- and Postmenopausal Healthy Women Measured with HR-pQCT
-
Abstract Number: 327
Drug Retention Rate of Oral Bisphosphonate in Patients with Rheumatoid Arthritis
-
Abstract Number: 328
A Study of Serum Electrolyte Levels after Denosumab Administration
-
Abstract Number: 329
Explore the Possible Mechanisms of 1,25(OH)2D3 on the Formation of Osteoclasts in Rheumatoid Arthritis
-
Abstract Number: 330
Safety of Denosumab in Postmenopausal Osteoporosis and in Cancer and Bone Metastase Treatment: A Systematic Review and Meta-Analysis
-
Abstract Number: 331
Biologic Disease-Modifying Anti-Rheumatic Drug Use and the Risk of Non-Vertebral Osteoporotic Fractures in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Cohort Study
-
Abstract Number: 332
A Comparison of Electronic and Manual Fracture Risk Assessment Tools in Screening US Veterans at Risk for Osteoporosis
-
Abstract Number: 333
An Assessment of Bone Health and Fracture Risk in a Bariatric Surgery Population at an Urban Medical Center
-
Abstract Number: 334
Predictors of Fragility Fractures in Patients with Rheumatoid Arthritis Not on Steroids: An Observational Study
-
Abstract Number: 335
High Risk of Osteoporosis and Long Term Joint Damage in Adults with a History of Juvenile Idiopathic Arthritis
-
Abstract Number: 336
The Risk of Subsequent Osteoporotic Fractures Is Decreased in Patients Experiencing Fracture While on Denosumab
-
Abstract Number: 337
Denosumab Treatment for 10 Years in Postmenopausal Women with Osteoporosis Was Associated with Substantially Lower Fracture Incidence Relative to Their Baseline FRAX-Predicted Probability
-
Abstract Number: 338
Abaloparatide-SC Significantly Reduces Vertebral and Nonvertebral Fractures and Increases Bone Mineral Density (BMD) Regardless of Age, BMD T-Score, or Prior Fracture at Baseline
-
Abstract Number: 340
Hydroxychloroquine: A Potential Treatment for Osteoporosis By Osteoclast Inhibition!
-
Abstract Number: 341
Evaluation of 25-Hydroxyvitamin D Levels in Rheumatologic Diseases
-
Abstract Number: 342
Presence of Vertebral Fractures and Disc Disease in Post Menopausal Females with Height Loss As a Possible Screening Method for Osteoporosis
-
Abstract Number: 343
Correlation Between Metacarpal Cortical Bone Mineral Density Measured By Dual X-Ray Densitometry and Radiogrammetry on Early Arthritis Patients
-
Abstract Number: 344
Is Rheumatoid Arthritis a Risk Factor for Fractures: A Systematic Review of Observational Studies
-
Abstract Number: 345
The Relationship Between Anti-Cyclic Citrullinated Peptide (anti-CCP) Levels and Bone Mineral Density (BMD) or Fragility Fracture in Patients with Rheumatoid Arthritis (RA)
-
Abstract Number: 346
Interest of Bone Texture Assessment By Trabecular Bone Score (TBS) in Kidney Transplants Recipients
-
Abstract Number: 347
Clinical Analysis of Tumor-Induced Osteomalacia Misdiagnosed As Spondyloarthritis: A Report of 18 Cases
-
Abstract Number: 348
Bisphosphonates-Related Atypical Femur Fractures: 8 Years’ Experience in a Single Center
-
Abstract Number: 349
Effects of Osteoporosis Treatments for Bone Loss and Pain-Related Behavior in the Hind Limb-Unloaded Mouse Model of Disuse Osteoporosis
-
Abstract Number: 350
Change in Bone Mineral Density with High-Dose Prednisone in Patients with Rheumatoid Arthritis
-
Abstract Number: 351
Pre-Operative Magnetic Resonance Imaging Can Help in Predicting Two-Year Readmission in Acute Severe Osteoporotic Vertebral Fracture after Vertebroplasty
-
Abstract Number: 352
Can Lumbar Spine Bone Mineral Density Predict Readmission in Denosumab-Treated Chronic Kidney Disease Patients?
-
Abstract Number: 353
Changes in Femoral Neck Bone Mineral Density Inverse Correlate with Egfr in Denosumab Treated Osteoporosis Patients? a Hospital-Based Analysis
-
Abstract Number: 354
A Longitudinal Cohort Study of Denosmab and Bisphosphonate for Prevention of Vertebral Fracture in Glucocorticoid-Induced Osteoporosis in Japanese
-
Abstract Number: 355
Fracture Incidence Rates in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
-
Abstract Number: 356
Osteoporotic Fracture As the Main Risk Factor in the Detection of Osteoporosis in Men Under 70 Years
-
Abstract Number: 357
Osteoporosis and Breast Cancer: Outcomes at a Specialized Osteoporosis Clinic Following a Structured Assessment
-
Abstract Number: 359
The Association of Scheuermann’s Disease with Osteoporotic Vertebral Fracture Risk
-
Abstract Number: 360
Osteoporosis Prevalence in Lung Transplant Patients
-
Abstract Number: 361
The Effect of Immunosuppressive and Antiresorptive Therapy on Bone Mineral Density in Lung Transplant Patients
-
Abstract Number: 362
Evaluation of Osteoporosis Risk Factors in Lung Transplant Patients
-
Abstract Number: 363
An Examination of Patient Knowledge and Education in Patients with Osteoporosis, Osteopenia and Normal Bone Mineral Density
-
Abstract Number: 364
Serum Sclerostin Levels in Rheumatoid Arthritis (RA) and Its Correlation with Disease Activity and Bone Mineral Density
-
Abstract Number: 365
Osteonecrosis of the Femoral Head Is Associated with Low Bone Mass.